Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories

被引:301
作者
Blaschke, Terrence F. [1 ,2 ]
Osterberg, Lars [1 ,3 ]
Vrijens, Bernard [4 ,5 ]
Urquhart, John [2 ,4 ]
机构
[1] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[2] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[3] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA
[4] AARDEX Grp Ltd, CH-1950 Sion, Switzerland
[5] Univ Liege, Dept Biostat, B-4000 Liege, Belgium
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 | 2012年 / 52卷
关键词
pharmionics; pharmacokinetics; pharmacodynamics; forgiveness; persistence; VARIABLE PATIENT COMPLIANCE; HEART-FAILURE; RESISTANT HYPERTENSION; BLOOD-PRESSURE; CLINICAL-PHARMACOLOGY; WITHDRAWAL PHENOMENA; SELF-REPORT; THERAPY; NONCOMPLIANCE; INTERVENTION;
D O I
10.1146/annurev-pharmtox-011711-113247
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Satisfactory adherence to aptly prescribed medications is essential for good outcomes of patient care and reliable evaluation of competing modes of drug treatment. The measure of satisfactory adherence is a dosing history that includes timely initiation of dosing plus punctual and persistent execution of the dosing regimen throughout the specified duration of treatment. Standardized terminology for initiation, execution, and persistence of drug dosing is essential for clarity of communication and scientific progress. Electronic methods for compiling drug dosing histories are now the recognized standard for quantifying adherence, the parameters of which support model-based, continuous projections of drug actions and concentrations in plasma that are confirmable by intermittent, direct measurements at single time points. The frequency of inadequate adherence is usually underestimated by pre-electronic methods and thus is clinically unrecognized as a frequent cause of failed treatment or underestimated effectiveness. Intermittent lapses in dosing are potential sources of toxicity through hazardous rebound effects or recurrent first-dose effects.
引用
收藏
页码:275 / +
页数:29
相关论文
共 101 条
  • [21] De Geest S, 2001, J Cardiovasc Nurs, V16, P1
  • [22] Demonceau J, 2011, INT C HIV TREAT PREV
  • [23] CONCENTRATION-EFFECT ANALYSIS OF ANTIHYPERTENSIVE DRUG RESPONSE - FOCUS ON CALCIUM-ANTAGONISTS
    DONNELLY, R
    ELLIOTT, HL
    MEREDITH, PA
    [J]. CLINICAL PHARMACOKINETICS, 1994, 26 (06) : 472 - 485
  • [24] OUTLOOK Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers
    Eichler, Hans-Georg
    Bloechl-Daum, Brigitte
    Abadie, Eric
    Barnett, David
    Koenig, Franz
    Pearson, Steven
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (04) : 277 - 291
  • [25] ON WHITE-COAT EFFECTS AND THE ELECTRONIC MONITORING OF COMPLIANCE
    FEINSTEIN, AR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (07) : 1377 - 1378
  • [26] Structural mean effects of noncompliance: Estimating interaction with baseline prognosis and selection effects
    Fischer, K
    Goetghebeur, E
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2004, 99 (468) : 918 - 928
  • [27] A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments
    Fischer, Krista
    Goetghebeur, Els
    Vrijens, Bernard
    White, Ian R.
    [J]. BIOSTATISTICS, 2011, 12 (02) : 247 - 257
  • [28] Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
    Fischer, Michael A.
    Stedman, Margaret R.
    Lii, Joyce
    Vogeli, Christine
    Shrank, William H.
    Brookhart, M. Alan
    Weissman, Joel S.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (04) : 284 - 290
  • [29] Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
    Garland, EJ
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (04) : 385 - 395
  • [30] Comparison of the effects of a 7-day period of noncompliance on blood pressure control using three different anti hypertensive agents
    Girvin, BG
    Johnston, GD
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 (07) : 1409 - 1414